SARS-CoV-2 infection: can ferroptosis be a potential treatment target for multiple organ involvement?

[1]  T. Vanden Berghe,et al.  Fatal lymphocytic cardiac damage in coronavirus disease 2019 (COVID‐19): autopsy reveals a ferroptosis signature , 2020, ESC heart failure.

[2]  X. Wan,et al.  SARS-CoV-2 suppresses mRNA expression of selenoproteins associated with ferroptosis, endoplasmic reticulum stress and DNA synthesis , 2020, bioRxiv.

[3]  Mark N. Wass,et al.  COVID-19-Related Coagulopathy—Is Transferrin a Missing Link? , 2020, Diagnostics.

[4]  G. Weiss,et al.  Prevalence and Predictive Value of Anemia and Dysregulated Iron Homeostasis in Patients with COVID-19 Infection , 2020, Journal of clinical medicine.

[5]  Y. Shoenfeld,et al.  COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy , 2020, Immunologic Research.

[6]  H. Krumholz,et al.  Extrapulmonary manifestations of COVID-19 , 2020, Nature Medicine.

[7]  V. Wong,et al.  Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement , 2020, The Lancet Gastroenterology & Hepatology.

[8]  Shuke Nie,et al.  Serum Iron Level as a Potential Predictor of Coronavirus Disease 2019 Severity and Mortality: A Retrospective Study , 2020, Open forum infectious diseases.

[9]  S. Tavakolpour,et al.  Lymphopenia during the COVID-19 infection: What it shows and what can be learned , 2020, Immunology Letters.

[10]  Mark N. Wass,et al.  COVID-19-related coagulopathy – Is transferrin a missing link? , 2020, bioRxiv.

[11]  C. Peyssonnaux,et al.  Iron: Innocent bystander or vicious culprit in COVID-19 pathogenesis? , 2020, International Journal of Infectious Diseases.

[12]  A. Lazo-Langner,et al.  Thrombosis risk associated with COVID-19 infection. A scoping review , 2020, Thrombosis Research.

[13]  Axel Haverich,et al.  Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. , 2020, The New England journal of medicine.

[14]  C. Ronco,et al.  Management of acute kidney injury in patients with COVID-19 , 2020, The Lancet Respiratory Medicine.

[15]  B. Stockwell,et al.  SnapShot: Ferroptosis , 2020, Cell.

[16]  Ying Yao,et al.  Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia. , 2020, Journal of the American Society of Nephrology : JASN.

[17]  Nils Kucher,et al.  Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy , 2020, Thrombosis Research.

[18]  S. Nekhai,et al.  Depriving Iron Supply to the Virus Represents a Promising Adjuvant Therapeutic Against Viral Survival , 2020, Current Clinical Microbiology Reports.

[19]  M. Nishimura,et al.  Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations , 2020, The Lancet Respiratory Medicine.

[20]  Ana Marusic,et al.  Novel Coronavirus Infection (COVID-19) in Humans: A Scoping Review and Meta-Analysis , 2020, Journal of clinical medicine.

[21]  Xinbing Sui,et al.  The emerging role of ferroptosis in inflammation. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[22]  Lei Dong,et al.  Kidney disease is associated with in-hospital death of patients with COVID-19 , 2020, Kidney International.

[23]  B. Stockwell,et al.  Transferrin Receptor Is a Specific Ferroptosis Marker , 2020, Cell reports.

[24]  P. Mehta,et al.  COVID-19: consider cytokine storm syndromes and immunosuppression , 2020, The Lancet.

[25]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[26]  Wei Liu,et al.  Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province , 2020, Chinese medical journal.

[27]  Yan Zhao,et al.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.

[28]  G. Wang,et al.  Ferroptosis: past, present and future , 2020, Cell Death & Disease.

[29]  Ting Yu,et al.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.

[30]  Ralph S. Baric,et al.  Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus , 2020, Journal of Virology.

[31]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[32]  Ping Chen,et al.  Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission , 2020, Science China Life Sciences.

[33]  R. Baric,et al.  Receptor recognition by novel coronavirus from Wuhan: 2 An analysis based on decade-long structural studies of SARS 3 , 2020 .

[34]  Marcus Conrad,et al.  The chemical basis of ferroptosis , 2019, Nature Chemical Biology.

[35]  T. Iwamoto,et al.  Involvement of cigarette smoke-induced epithelial cell ferroptosis in COPD pathogenesis , 2019, Nature Communications.

[36]  T. Vanden Berghe,et al.  Targeting Ferroptosis to Iron Out Cancer. , 2019, Cancer cell.

[37]  D. Pang,et al.  Ferritinophagy is required for the induction of ferroptosis by the bromodomain protein BRD4 inhibitor (+)-JQ1 in cancer cells , 2019, Cell Death & Disease.

[38]  B. Li,et al.  Ferroptosis, a new form of cell death: opportunities and challenges in cancer , 2019, Journal of Hematology & Oncology.

[39]  A. Sher,et al.  A major role for ferroptosis in Mycobacterium tuberculosis–induced cell death and tissue necrosis , 2019, The Journal of experimental medicine.

[40]  Yanhang Gao,et al.  Iron metabolism disorders in patients with hepatitis B-related liver diseases , 2018, World journal of clinical cases.

[41]  P. Vandenabeele,et al.  Discovery of Novel, Drug-Like Ferroptosis Inhibitors with in Vivo Efficacy. , 2018, Journal of medicinal chemistry.

[42]  M. Conrad,et al.  Ferroptosis and necroinflammation, a yet poorly explored link , 2018, Cell Death & Differentiation.

[43]  T. Vanden Berghe,et al.  Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma , 2018, The Journal of clinical investigation.

[44]  M. Shchepinov,et al.  Resolving the Role of Lipoxygenases in the Initiation and Execution of Ferroptosis , 2018, ACS central science.

[45]  H. Manceau,et al.  Iron metabolism and the role of the iron-regulating hormone hepcidin in health and disease. , 2017, Presse medicale.

[46]  Wanling Sun,et al.  Relationship between Hepatitis C Virus Infection and Iron Overload , 2017, Chinese medical journal.

[47]  B. Stockwell,et al.  Lipid peroxidation in cell death. , 2017, Biochemical and biophysical research communications.

[48]  Simon C Watkins,et al.  Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. , 2017, Nature chemical biology.

[49]  Q. Pan,et al.  Ferroptosis is an autophagic cell death process , 2016, Cell Research.

[50]  M. Lotze,et al.  Autophagy promotes ferroptosis by degradation of ferritin , 2016, Autophagy.

[51]  D. Tang,et al.  Ferroptosis: process and function , 2016, Cell Death and Differentiation.

[52]  G. Bornkamm,et al.  T cell lipid peroxidation induces ferroptosis and prevents immunity to infection , 2015, The Journal of experimental medicine.

[53]  A. Walch,et al.  Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice , 2014, Nature Cell Biology.

[54]  D. Green,et al.  Synchronized renal tubular cell death involves ferroptosis , 2014, Proceedings of the National Academy of Sciences.

[55]  John A. Tallarico,et al.  Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo , 2014, Nature Cell Biology.

[56]  Antonio Ayala,et al.  Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal , 2014, Oxidative medicine and cellular longevity.

[57]  S. Gygi,et al.  Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy , 2014, Nature.

[58]  Douglas B Kell,et al.  Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells. , 2014, Metallomics : integrated biometal science.

[59]  G. Anderson,et al.  The regulation of iron transport , 2014, BioFactors.

[60]  M. R. Lamprecht,et al.  Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death , 2012, Cell.

[61]  J. Haeggström,et al.  Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease. , 2011, Chemical reviews.

[62]  S. Radoshitzky,et al.  Transferrin receptor 1 in the zoonosis and pathogenesis of New World hemorrhagic fever arenaviruses , 2011, Current Opinion in Microbiology.

[63]  H. Drakesmith,et al.  Viral infection and iron metabolism , 2008, Nature Reviews Microbiology.

[64]  M. Kaito,et al.  Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C , 2007, Journal of gastroenterology and hepatology.

[65]  D. Meyer,et al.  The effect of iron overload on in vitro HIV-1 infection. , 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[66]  P. Ponka,et al.  Human cytomegalovirus-induced host cell enlargement is iron dependent. , 2004, American journal of physiology. Cell physiology.